Chemotherapy and irradiation can affect the gonads, leading to impairment of pubertal development and/or infertility. Fertility preservation (FP) is therefore a crucial endeavor in hematopoietic stem cell transplantation (HSCT) because of the severe impact of infertility on the quality of life of long-term survivors. Despite the existence of different international guidelines, FP counseling and procedures are not routinely implemented as part of patient care. We present herein a survey conducted by the Pediatric Working Party of the European Society for Blood and Marrow Transplantation (EBMT), which aims to analyze and compare different FP practices for children and adolescents across EBMT centers in 2013. A total of 177 pediatric centers reporting to the EBMT were contacted; of this number, 38 centers (21%) located in 16 different countries responded. These centers reported 834 patients receiving HSCT in 2013 (73% prepubertal), corresponding to 22% of all children (n = 3789) undergoing HSCT in EBMT reporting centers. Overall, 39% of the reported patients received counseling and 29% received an FP procedure. The increased need for FP programs, extended education for patient-care teams, and more personal resources and funding emerged from this survey as pivotal factors necessary to support and implement such programs. ( Conditioning regimes, particularly the use of alkylating agents, and TBI (4600 cGy) can lead to gonadal impairment and even infertility; for example, studies have shown a 71% increase in azoospermia among young men and 56% increase in ovarian failure among young women undergoing these treatments.
INTRODUCTION
Fertility preservation (FP) is important in oncology, especially in the field of stem cell transplantation in the pediatric population. Conditioning regimes, particularly the use of alkylating agents, and TBI (4600 cGy) can lead to gonadal impairment and even infertility; for example, studies have shown a 71% increase in azoospermia among young men and 56% increase in ovarian failure among young women undergoing these treatments. 1, 2 Moreover, infertility is associated with a reduced quality of life, and infertility patients suffer from psychosocial distress, anxiety and low self-esteem. [3] [4] [5] Several groups have recognized the importance of FP in young patients, and many guidelines regarding FP counseling and procedures, especially for children, have been published in recent years. [6] [7] [8] [9] Despite the increasing number of long-term survivors, considerable progress in reproductive medicine, and the existing recommendations, FP is still not routinely implemented and only 40% of all eligible patients receive FP counseling before treatment. 10 Possible barriers include the patients' health conditions, attitudes, and time constraints, as well as institutional factors. 11 Herein, we present the results of the European Society for Blood and Marrow Transplantation (EBMT) Pediatric Working Party investigation of FP counseling and procedures performed in pediatric and adolescent cancer patients undergoing HSCT in 2013 in one of 177 EBMT centers. The aim of this survey is to analyze different FP practices in Europe and determine the possible obstacles barring their broader implementation.
MATERIALS AND METHODS
On behalf of the EBMT Pediatric Working Party, all 177 EBMT centers transplanting children and adolescents were contacted to participate in this survey, which was conducted from October 2014 to December 2015. A questionnaire was sent via email to the heads of each department of the 177 EBMT reporting centers. The questionnaire contained 24 questions divided into four sections: (1) demographic information about each center; (2) the availability of counseling and/or a standard operating procedure (SOP) for FP, the time point of counseling, and the responsible persons/ teams; (3) applied FP procedures; and (4) the physicians' own views concerning barriers to and the relevance of FP counseling. Questions concerning the coverage of costs and suggestions for improvement of FP procedures were also included. We further requested information related to the number and type of FP methods available in each center and the number of FP procedures performed in 2013 for each transplanted disease. The population of interest for this survey consisted of children and adolescents younger than 18 years old at diagnosis with malignant or nonmalignant disease undergoing their first HSCT. Patients with previous HSCT were excluded from the survey.
Exploratory data analysis was summarized to provide information of pediatric hematology oncology units of the EBMT centers with regard to the existence of an SOP for FP. Data were assessed visually using scatterplots, barplots, boxplots, and maps to identify patterns, trends, and outliers, and all analyses were performed using R software.
RESULTS
Thirty-eight out of 177 contacted centers located in 16 different countries agreed to participate in the survey and completed the questionnaire (response rate, 21.5%). The demographic characteristics of participating centers are described in Table 1 . The participating centers reported data from a total of 834 children and adolescents with HSCT as part of treatment performed in 2013. This number corresponds to 22% of all transplanted children (n = 3789) registered in the EBMT registry for the year. 12 The characteristics of all 834 patients receiving HSCT are summarized in Table 2 .
Twenty-one out of 38 responding centers (55%) had a standardized program for FP counseling and procedures (16 centers reported programs for pre-and postpubertal patients; five centers reported programs for postpubertal patients only). Most of the SOPs were only recently implemented (range, 1-15 years; median 3 years), and the majority of these procedures were in-house protocols elaborated upon by local specialists of reproductive medicine based on international guidelines. 13, 14 In 27/38 (71%) centers, 17 with an SOP, FP counseling was the responsibility of an interdisciplinary team consisting of a pediatric hematologist/oncologist, a pediatric endocrinologist, and a specialist in reproductive medicine (Table 3) . In seven centers, four without an SOP, a hematologist/oncologist conducted the FP counseling alone. FP counseling was offered in 18/38 centers (47%), 14 with an SOP, before treatment started and in 22/38 centers (58%), 15 with an SOP, just before HSCT (Table 3) .
Of the 834 patients treated with HSCT, 322 (39%) received FP counseling and 58% were prepubertal. Overall, 29% (243/834) of all pediatric HSCT recipients in 38 centers benefited from an FP measure in 2013. Centers with an FP program counseled patients significantly more often than centers without (Figure 1a) . No significant difference in terms of the number of applied procedures between centers with and without an SOP was found (Figure 1b) . Abbreviations: CIC = centre identification code; EBMT = European Society for Blood and Marrow Transplantation; HSCT = hematopoietic stem cell transplantation; NR = not reported; SOP = standard operating procedure. Abbreviations: FP = fertility preservation; HSCT = hematopoietic stem cell transplantation.
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To preserve fertility, the most frequently used procedures in females were ovarian suppression with GnRHa and ovarian tissue cryopreservation ( Figure 2a ). In males, the procedure most frequently used to preserve fertility was sperm cryopreservation (Figure 2b ). Different treatment procedures applied as reported by 14 centers are listed in Table 4 according to the type of cancer treated.
A total of 11/38 centers (29%) offered all of the following FP options to women: conservative surgical treatment of the gonads, oophoropexy, ovarian suppression with GnRHa, gonadal shielding, oocyte cryopreservation and ovarian tissue cryopreservation. Two centers offered all of the available FP procedures for males, including sperm cryopreservation, testicular sperm extraction, gonadal shielding, testicular hormonal suppression and spermatogonial stem cell cryopreservation.
In 2013, not all proposed FP procedures were allowed in the 16 participating countries. Embryo cryopreservation, for example, was prohibited in Italy, and ovarian tissue cryopreservation was not allowed in Lithuania and Sweden. In Switzerland, spermatogonial stem cell cryopreservation was not allowed; and in the Czech Republic, Lithuania, and Holland, testicular sperm extraction and spermatogonial stem cell transplantation were prohibited.
The cost of FP procedures was principally covered by public health systems, the government or charities (55%), and by health insurance companies (42%). About 39% of the parents of patients bore the costs of FP procedures (Table 5) .
Parental interest in FP issues was, according to the reporting physicians, generally high (92% of all parents of postpubertal patients; 86% of all parents of prepubertal patients). As well, 84% of all postpubertal patients and 34% of prepubertal patients were interested in the topic of FP.
In 17 centers, not all eligible patients routinely received counseling, the most frequently cited reasons for which included a lack of time (10/17, 59%), refusal by parents (6/17, 35%), and poor prognosis of the primary disease (5/17, 29%). Some physicians cited psychological distress in a life-threatening situation (20/38), the overwhelming nature of the situation (19/38), and a lack of interest (16/38) as possible reasons for the refusal of counseling by parents/patients. One center reported financial considerations as a reason for refusal.
Physicians rated FP as highly relevant (range, 1-10; mean, 8.0) (Figure 3a) . However, no association between the considered relevance and number of counseled patients (Figure 3b ) was observed. Abbreviations: FP = fertility preservation; HSCT = hematopoietic stem cell transplantation; SOP = standard operating procedure. 
Physicians further cited better coping with the diagnosis (47%) and less psychological distress (32%) as potential benefits of FP counseling. Nine centers (24%, 6 without an SOP) were concerned about the risk of delay in treatment start because of FP counseling and procedures.
More post-graduate and continuous education courses in the field of FP, more specialized personal resources, and more private or public financial support were suggested as pivotal factors facilitating the wider implementation of FP programs.
DISCUSSION
FP is essential in pediatric HSCT because of the deleterious impacts of conditioning regimens on testicular or ovarian function, generally leading to infertility. The psycho-social impact of cancer-related infertility is often underestimated by oncologists, surgeons, and gynecologists. 15 The present survey, with a 21% response rate, presents a participation rate similar to those reported for other surveys. 16 Our survey showed that half of all participating pediatric EBMT centers had a program in which FP counseling was an integral part of patient care. Most of these programs were in-house protocols based on international guidelines, such as ASCO guidelines. 7 These data are comparable with those previously reported (42%) by Terenziani et al. 10 . Compared with centers without an SOP, EBMT centers with an established SOP provided counseling significantly more often at an earlier time point and in the framework of a multidisciplinary team. Thus, center size does not appear to influence whether a center has a program; instead, the presence of a dedicated individual promoting the development of the program was an important determinant of the successful establishment of such a program.
The availability of a standardized program is known to enhance the application of existing recommendations and implementation of FP procedures before treatment start and/or before HSCT; such a program may also facilitate patients' decision making about FP. 9 The absence of an SOP significantly increases the risk of variability of practices 17 and could present a barrier to counseling. Ideally, in the FP process, the pediatric hematologist/oncologist, as a treating doctor, has a central role; this pivotal role requires the proper management of information with the patient and his/her family. However, the pediatric hematologist/ oncologist may not always be familiar with the current practices and available FP technologies. Counseling by an interdisciplinary team consisting of a specialist in reproductive medicine or a gynecologist, a pediatric endocrinologist, a specialist nurse, and the pediatric hematologist/oncologist can help optimize the process by implementing systematic information exchange and case reviews. 9 The survey showed that 29% of all patients receiving HSCT also underwent an FP procedure. The most frequently used procedures among prepubertal and postpubertal females were ovarian tissue cryopreservation and hormonal suppression with GnRHa, respectively. Ovarian tissue cryopreservation, which is no longer considered an experimental technique, is currently the only recommended option for prepubertal girls. 7 Continuing in vitro maturation from the germinal vesicle-stage oocyte also presents Fertility preservation in European children T Diesch et al a promising technique for potential maximal FP in young girls for whom cancer therapy has already been initiated. 18 Ovarian tissue cryopreservation presents a number of advantages, including immediate practicability, no requirement for additional hormonal stimulation, and the possibility of implementation without causing any delay in treatment initiation. However, the intervention itself, which is usually realized by laparoscopy under general anesthesia, presents some risk of bleeding or infection, which is certainly increased in patients with aplasia. A serious concern of the use of this technique in patients with leukemia, lymphoma, or neuroblastoma is the possible reimplantation of malignant cells. 19, 20 The low prevalence reported for cryopreservation of ovarian tissue in transplanted patients with malignant diseases in this survey may be related to this risk. To overcome this concern, Wallace et al. 21 proposed that some centers consider a risk stratification approach and suggest this intervention only for patients with a high risk of infertility. Anticipating future progress in the field, we feel that performing the process, reserving its wider uptake until scientific developments allow its safe use, is acceptable.
Administration of GnRH agonists during chemotherapy, a simple and very practicable option, was the most frequently used treatment method in postpubertal girls. The clinical efficacy of GnRH agonists in protecting patients from chemotherapyinduced ovarian damage remains controversial. Several studies and meta-analyses, mainly among breast cancer patients, have been published in the few last years, and these works show mixed results. 22, 23 Recently published data indicate associations between GnRHa administration and reduced ovarian failure and higher rates of successful pregnancies. In males, sperm cryopreservation clearly stands out from other procedures. Established for decades, this method is easily practicable and non-invasive, and its use does not delay cancer therapy. 24 The high number of such interventions recorded in our survey confirms these data. In adolescents, attempts at sperm cryopreservation may be hindered by some difficulties, such as the inability to ejaculate due to psychological distress or poor semen quality 25, 26 as a consequence of the underlying disease. 27 Testicular sperm extraction is a safe and effective option for postpubertal boys 28 but its use was reported in only a few cases in this survey. Lack of knowledge of this technology in the pediatric hemato-oncology community and the necessary slight delay of treatment start may explain its low use.
Prepubertal boys present a significant challenge to FP because the only option that can be offered at the moment is cryopreservation of spermatogonial stem cells. 29 This procedure has emerged only in recent years and was not allowed in all participating countries at the time the EBMT survey was carried out; in fact, only 11 centers offered this method as an FP option. Spermatogonial stem cell cryopreservation represents a highly experimental technique and has only been proven to be effective in a mouse model; thus, its acceptance by professionals and parents is low, 30 in line with the low prevalence of its use reported in this survey.
Our study shows that the presence of an FP program in an EBMT center does not influence the number of procedures performed. Possible explanations for this finding include the global standardization of some practices, such as sperm cryopreservation, in postpubertal patients 31 but the experimental use of this procedure in prepubertal patients. A limitation that cannot be neglected in the field of FP is the cost of the procedures and their coverage by national health systems. Our survey showed great variability in the coverage of these costs, not only among countries but also among centers in a given country. High costs can deter improvements in patient care. A general obligation for health insurance companies to cover FP costs in oncological patients appears to be an urgent but unmet need.
A very positive and encouraging finding of the survey is that FP is considered a highly relevant topic by pediatric hematooncologists. Nevertheless, acknowledgment of the problem seems to have a poor impact on the number of patients receiving counseling or treatment. We hypothesize that institutional Fertility preservation in European children T Diesch et al recognition of the crucial role of FP, resulting in the creation of local SOPs, may be a concrete contribution to the field.
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Patient wishes may be sometimes be underestimated by the treating physicians, 3 resulting in lost opportunities to discuss important issues. Our data indicated that from a physician's point of view, parents and patients, including prepubertal patients, generally have great interest in the topic of FP.
This survey explored possible parental barriers to FP as referred from a physician's point of view. Physicians reported some parents rejecting the necessary procedure when psychologically overwhelmed by the critical condition of their child. HSCT is recognized as one of the most stressful events that a child and his or her family can experience. When fully focused on a current life-threatening situation, some families are unable to contemplate later consequences, such as the future infertility of their child. These families may experience difficulty in decision making, especially if an additional surgical intervention is necessary and the proposed options remain under investigation. Other reported reasons that can cause parents to refuse FP counseling or FP procedures include religious, cultural, and ethical motivations.
Physicians reported the urgent need to commence treatment because of the medical condition of the patient as a primary barrier to FP counseling. Many physicians also believe that survival is a greater consideration than future fertility. In stressful situations, a standardized program could be helpful for the team.
This survey further aimed to collect suggestions for FP improvement, and three items werehighlighted: continuous medical education, access to specialized teams, and increased financial support. Continuous education on fertility issues increases awareness and knowledge and provides physicians with the confidence to discuss FP prospects with patients and their families. Interdisciplinary FP teams are pivotal in promoting high-level teaching in this field.
This survey features a number of constraints that should be interpreted as study limitations. The questionnaire was completed by only one professional per institution, which means some responses, particularly those related to physicians' views concerning barriers to and the relevance of FP questioning, may include bias. Centers without a relevant program may also have chosen not to answer the questionnaire.
CONCLUSIONS
This is the first survey reporting the current practices in fertility counseling and FP practices in children and adolescents who underwent HSCT in EBMT centers. FP was implemented in 55% of the participating centers. Broader education, financial support, and resources were identified as crucial incentives for the systematic implementation of FP programs in Europe. On the basis of these results, uniform FP guidelines should be written within the EBMT community to place FP as an integral part of patient care.
